Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Genetics and Genomics, |
RCV001269997 | SCV001450406 | pathogenic | not provided | 2018-11-05 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001331279 | SCV001523290 | uncertain significance | Metaphyseal chondrodysplasia, Schmid type | 2020-04-14 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV001269997 | SCV005834555 | likely pathogenic | not provided | 2025-01-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp651*) in the COL10A1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 30 amino acid(s) of the COL10A1 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Schmid type metaphyseal dysplasia (PMID: 16088909). ClinVar contains an entry for this variant (Variation ID: 988566). This variant is located in a region of the COL10A1 protein where a significant number of COL10A1 nonsense and frameshift mutations have been reported in association with autosomal dominant metaphyseal chondrodysplasia (PMID: 21447328, 33764685, 36400164). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |